Get the Stockscreener App
6.83
8.93%
0.56
After Hours:
6.83
Apollomics Inc stock is traded at $6.83, with a volume of 36,414.
It is up +8.93% in the last 24 hours and up +18.17% over the past month.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
See More
Previous Close:
$6.27
Open:
$6.27
24h Volume:
36,414
Relative Volume:
1.06
Market Cap:
$7.54M
Revenue:
-
Net Income/Loss:
$-57.11M
P/E Ratio:
-0.4553
EPS:
-15
Net Cash Flow:
$-34.82M
1W Performance:
+32.36%
1M Performance:
+18.17%
6M Performance:
-15.68%
1Y Performance:
-48.34%
1-Day Range:
$6.27
$7.00
1-Week Range:
$5.20
$7.00
52-Week Range:
$3.659
$35.98
Apollomics Inc Stock (APLM) Company Profile
Compare APLM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
6.83 | 13.27M | 0 | -57.11M | -34.82M | -15.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Apollomics Inc Stock (APLM) Latest News
Is Apollomics Inc. Equity Warrant stock entering bullish territoryJuly 2025 Patterns & Risk Controlled Stock Pick Alerts - Newser
Measuring Apollomics Inc. Equity Warrant’s beta against major indicesGap Up & Daily Oversold Bounce Ideas - Newser
Comparing Apollomics Inc. Equity Warrant in custom built stock radars2025 Short Interest & Free Growth Oriented Trading Recommendations - Newser
What data driven models say about Apollomics Inc. Equity Warrant’s futureWeekly Trade Analysis & Risk Controlled Swing Alerts - Newser
Apollomics Inc. stock chart pattern explainedJuly 2025 Sentiment & Stock Portfolio Risk Management - Newser
What MACD and RSI say about Apollomics Inc. Equity WarrantQuarterly Portfolio Report & Advanced Swing Trade Entry Plans - Newser
Using flow based indicators on Apollomics Inc. Equity WarrantPortfolio Return Report & Detailed Earnings Play Alerts - Newser
Apollomics Inc. Equity Warrant stock outlook for YEAR2025 Price Momentum & Short-Term Trading Alerts - Newser
Analyzing Apollomics Inc. with multi timeframe charts2025 Winners & Losers & Weekly Setup with High ROI Potential - Newser
Analyzing net buyer seller activity in Apollomics Inc. Equity WarrantWeekly Trend Summary & Risk Controlled Stock Pick Alerts - Newser
Statistical indicators supporting Apollomics Inc.’s strengthM&A Rumor & Community Trade Idea Sharing Platform - Newser
Chart overlay techniques for tracking Apollomics Inc.July 2025 Drop Watch & Capital Protection Trading Alerts - Newser
Apollomics Inc. Equity Warrant stock daily chart insightsJuly 2025 Market Mood & Scalable Portfolio Growth Ideas - Newser
News impact scoring models applied to Apollomics Inc.Price Action & Real-Time Volume Trigger Notifications - Newser
How to track smart money flows in Apollomics Inc.Price Action & Stepwise Entry and Exit Trade Signals - Newser
Analyzing Apollomics Inc. Equity Warrant with multi timeframe chartsSell Signal & Low Drawdown Trading Techniques - Newser
Using Ichimoku Cloud for Apollomics Inc. Equity Warrant technicals2025 Earnings Surprises & Capital Efficiency Focused Strategies - Newser
Live market analysis of Apollomics Inc. Equity WarrantEarnings Growth Report & High Accuracy Swing Trade Signals - Newser
Signal strength of Apollomics Inc. Equity Warrant stock in tech scanners2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser
How to integrate Apollomics Inc. into portfolio analysis toolsJuly 2025 News Drivers & Safe Entry Trade Signal Reports - Newser
Regression analysis insights on Apollomics Inc. performanceJuly 2025 WrapUp & Weekly Sector Rotation Insights - Newser
Relative strength of Apollomics Inc. in sector analysisGDP Growth & Safe Entry Trade Reports - Newser
Real time social sentiment graph for Apollomics Inc.Earnings Growth Summary & Daily Entry Point Trade Alerts - Newser
Is it time to cut losses on Apollomics Inc.Trade Entry Report & Step-by-Step Swing Trade Plans - Newser
Will Apollomics Inc. Equity Warrant rebound enough to break evenJuly 2025 Opening Moves & Entry and Exit Point Strategies - Newser
Backtesting results for Apollomics Inc. trading strategies2025 Key Lessons & Growth Focused Entry Reports - Newser
Relative strength of Apollomics Inc. Equity Warrant in sector analysisQuarterly Earnings Report & Consistent Profit Trading Strategies - Newser
Tools to monitor Apollomics Inc. Equity Warrant recovery probabilityIndex Update & Free Community Supported Trade Ideas - Newser
Apollomics Inc Stock (APLM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):